Inhibition of ATF5 activity, using RNAi or a dominant negative form of ATF5, kills human and rat glioblastoma cells but does not affect normal cells surrounding the tumor, indicating ATF5 is selectively essential for the survival of glioblastoma cells [24, 45]. The gene discussed is ATF5; the disease is neoplasm.